Breast pathology and cancer conferences |oslo, norway | europe

Theme: Revolutionizing the different diagnostic approaches in Breast pathology

Breast pathology and Cancer-2019

program schedule

Renowned Speakers

Shahla Masood
Professor at University of Florida
USA

Namsun Paik
Ewha Womans Cancer Center Hospital for Women.
South Korea

Kais Razzouk
Institut du Sein Nice Santa Maria- Nice - France Breast and Gynecological Cancer Surgeon
France

Mandy Sanghera
International human rights activists
UK

David Ling
Stanford University
USA

Yihui Feng
Guangzhou University of Chinese Medicine,China
China

Ioannis G. Papanikolaou
Obstetrician & Gynaecologist
Greece

Breast pathology and Cancer-2019

Breast Pathology 2019 extends its welcome to you during June 28-29, 2019 at Oslo, Norway with a theme “Revolutionizing the different diagnostic approaches in Breast pathology’’. Breast Pathology 2019 Conference aims to bring together the Professors, Researchers, scientists, business giants and technocrats to provide an international forum for the dissemination of original research results, new ideas and practical development and discover advances in health practice, management and education in relation to health disparities as well as a breadth of other topics. You can refresh your insights about the current circumstance of Breast Cancer and get name and acknowledgment at this 2-day occasion. This meeting will give the stage to share thoughts. Incredibly famous speakers with their definitive chats on the latest methods, strategies in therapeutics of Breast Pathology are the signs of this meeting.

Importance & Scope:

Breast Pathology 2019 deals with Breast cancer knowledge and characteristics, Screening, Detecting and Diagnosing Breast Cancer, Breast cancer therapy, prevention and medicine, Surgery Choices for Breast Cancer, Personalized Medicine, Clinical trials of Breast Cancer, Male Breast Cancer and Breast cancer Nursing. Breast cancer is the main type of cancer from which most of the women are suffering worldwide. Awareness about the breast cancer risks, symptoms and treatment is very essential. Introduction of new techniques in the field of medicine as well as diagnosis is going on worldwide. Breast Pathology 2019 provides a platform for sharing of information about the breast cancer treatment techniques and newly developed techniques for the same as well as provide platform about the recent researches on breast cancer. This event includes prompt keynote presentations, oral talks, Pleenary speeches, poster presentations, Video Presentations and exhibitions.

Why Oslo?

Oslo is a cosmopolitan hub with an abundance of world-class architecture, museums, restaurants and shopping. As one of Europe’s fastest growing cities, Oslo is buzzing with energy from new neighbourhoods and cutting-edge food, to fashion and art scenes. Captivating landmarks like the Opera House, the Astrup Fearnley Museum and Barcode are changing the face of the city, and Oslo maintains its refreshing closeness to nature that few other capitals can match. Oslo, the capital of Norway, sits on the country’s southern coast at the pinnacle of the Oslofjord. Norway’s capital since 1814, Oslo is home to many of the country’s most prestigious cultural institutions. Nestled between the Oslofjord and forested hills, Oslo was named European Green Capital 2019 for its dedication to conserving natural areas and reducing pollution. The compact city centre is easy and safe to explore on foot or by bike, and the efficient public transport system makes the entire city accessible without a car. Oslo is also in the process of being certified as a Sustainable Destination, a seal of approval given to destinations that work systematically to reduce the negative impact of tourism.

Oslo is one of the Scandinavian capitals. Like you probably know, Scandinavia is the world's richest territory. Trust me; a visit here will guarantee you the best hospitality in the world. Tourists that have been to Oslo are often surprised for being served like royalty - even those on lean budgets. Don’t be surprised, this is how things are done in Scandinavia.

Breast Cancer

Breast cancer starts in the breast tissue, most commonly in the cells that line the milk ducts of the breast. When cells of breast begin to grow out of control it leads to breast cancer It mainly affects women but men can get it too. Cancer that develops from breast cells is known as Breast Cancer. In females worldwide breast cancer is the most common invasive cancer. Tumor formed by these cells can be seen on an x-ray or felt as a lump. When tumor cells grow into surrounding tissues or spread to distant areas of the body it become malignant. From the different parts of breast, breast cancer can develop. But most of the time the ducts that carry milk to nipple act as site for breast cancer. It may also start from the glands that make breast milk. Sarcomas and lymphomas are not really considered as breast cancer but they can also start from other tissues in the breast. Lump in the breast are not cancer but they are benign which means they will not spread out, but are abnormal growths. They can increase the risk for woman of getting breast cancer. When breast cancer cells enter blood or lymph system can spread the cancer and carry to the other part of the body.

Related societies and associations:

Related pathology conferences

15th International CME Congress on American Pathology and Oncology Research December 03-04, 2018 Chicago, USA ; European Pathology and Infectious Disease Conference November 26-27, 2018 Helsinki, Finland ; 3rd International Conference on Internal Medicine & Hospital Medicine October 15-16, 2018 Ottawa, Ontario, Canada ; 10th World Congress on Precision and Personalized Medicine October 5-6, 2018 Osaka, Japan ; International Conference on Breast Pathology and Cancer Diagnosis August 12, 13, 2019 Boston, USA ; International Conference on Laboratory Medicine & Pathology July 22-23, 2019 London, UK ; 15th International Conference on Surgical Pathology and Cancer Diagnosis April 15-16, 2019 Berlin, Germany ; 17th European Pathology Congress May 9-10, 2019 | Amsterdam, Netherlands

Breast Anatomy

The breast is highly complex. It goes through more changes than any other part of the human body – from birth, puberty, pregnancy and breastfeeding, right through to menopause. Breast tissue extends from the collarbone, to lower ribs, sternum (breastbone) and armpit. Each breast contains 15-20 glands called lobes, where milk is produced in women who are breastfeeding. These lobes are connected to the nipple by 6-8 tubes called ducts which carry milk to the nipple. The breast and armpit contain lymph nodes and vessels carrying lymph fluid and white blood cells. Much of the rest of the breast is fatty tissue. The breast, like any other part of the body, consists of billions of microscopic cells. These cells usually multiply in an orderly fashion – new healthy cells continue to divide and replace the ones that have died. However, sometimes cells develop abnormalities (mutations). This occurs when the genes that usually check that cells are replicating correctly fail to detect mutations. When this happens, abnormal cells continue to divide and multiply, sometimes growing quite rapidly.

Related societies and associations:

Related pathology conferences:

Diagnostic Pathology Update, July 7-12, 2019, California; 15th International Conference on Surgical Pathology and Cancer Diagnosis, April 15-16, 2019, Germany; The Hawaii Pathology Conference, January 28-February 1, 2019, Hawaii, Advances in Surgical Pathology Conference, January 10-11, 2019, Singapore; 7th Euroscicon Conference on Pathology and Bacterial Diseases, February 27-28, 2019, Czech Republic; 2nd International Conference on Pathology and Case reports, May 13-14, 2019, Kuala Lumpur, Malaysia, 5th International Conference on Cytopathology and Histopathology, June 26-27, 2019, Canada | International Conference on Breast Pathology and Cancer Diagnosis August 12, 13, 2019 Boston, USA

Benign Breast conditions

Benign (not cancer) breast conditions are very common and most breast changes are not cancer. A benign breast condition refers to a lump, cyst, or nipple discharge (fluid) of the female or male breast that is not cancerous. There are numerous benign breast conditions. For women, the most common ones are: Fibrocystic breast changes, Fibro adenomas, Mastitis, Fat necrosis, Calcification, Nipple discharge. Less common types of benign breast conditions include: Hyperplasia, Adenosis, Intraductal papillomas, Lipoma. Benign breast conditions are generally caused by a number of factors. Those factors include the makeup of breasts (fatty tissue vs. dense or thick tissue), age, hormone problems, hormone therapy, birth control pills, pregnancy, menopause, being overweight, infection, and breastfeeding. The exact cause can often be traced back to your specific diagnosis. These are rare in men. Men do have undeveloped milk ducts. The most common benign breast condition in men is called gynecomastia this condition enlarges breast tissue. It is caused by a hormone imbalance and hormone therapy, some diseases, and being severely overweight.

Related societies and associations:

Related pathology conferences:

Ductal carcinoma In Situ

DCIS is an early form of breast cancer and accounts for about 12% of all breast cancers. When cancer cells have developed within the ducts of the breast but remain within the ducts (‘in situ’), it is called DCIS. The cancer cells have not yet developed the ability to spread outside these ducts into the surrounding breast tissue or to other parts of the body. As a result of being confined to the ducts, DCIS has a very good prognosis. If DCIS is left untreated, the cancer cells may develop the ability to spread outside the ducts, into the surrounding breast tissue. This is known as invasive breast cancer. Invasive cancer has the potential to also spread to other parts of the body. In some cases, DCIS will never develop further or grows so slowly that it would never cause harm during that person’s lifetime. Although the size and grade of the DCIS can help predict if it will become invasive, there is currently no way of knowing if this will happen. High-grade DCIS is more likely to become an invasive breast cancer than low-grade DCIS and do so more quickly. Although DCIS is an early form of breast cancer with a very good prognosis, people understandably may feel very anxious and frightened by the diagnosis. People can often struggle to come to terms with being offered treatments such as a mastectomy, at the same time as being told their DCIS may never do them any harm.

Related societies and associations:

Related pathology conferences:

Lobular carcinoma In Situ

Lobular carcinoma in situ (LCIS) is an uncommon condition in which abnormal cells form in the milk glands (lobules) in the breast. LCIS isn't cancer. But being diagnosed with LCIS indicates that you have an increased risk of developing breast cancer. It begins when cells in a milk-producing gland of a breast develop genetic mutations that cause the cells to appear abnormal. The abnormal cells remain in the lobule and don't extend into, or invade, nearby breast tissue. LCIS is viewed as an uncommon condition, but we don’t know exactly how many people are affected. That’s because LCIS does not cause symptoms and usually does not show up on a mammogram. It tends to be diagnosed as a result of a biopsy performed on the breast for some other reason. It is usually diagnosed before menopause, most often between the ages of 40 and 50. Less than 10% of women diagnosed with LCIS have already gone through menopause. This is extremely uncommon in men. This is described as pleomorphic or if it has necrosis (areas of dead cells), in which case it might be more likely to grow quickly.

Related societies and associations:

Related pathology conferences:

Atypical hyperplasia

Atypical hyperplasia is a precancerous condition that affects cells in the breast. It describes an accumulation of abnormal cells in the breast which isn't cancer, but it can be a forerunner to the development of breast cancer. Over the course of your lifetime, if the atypical hyperplasia cells keep dividing and become more abnormal, this can transit into non-invasive breast cancer (carcinoma in situ) or invasive breast cancer. If you've been diagnosed with atypical hyperplasia, you have an increased risk of developing breast cancer in the future. For this reason, doctors often recommend intensive breast cancer screening and medications to reduce breast cancer risk. Atypical hyperplasia typically doesn't cause symptoms, but it may cause changes to appear on a mammogram. Atypical hyperplasia is usually discovered during a breast biopsy to investigate an abnormality found on a mammogram. Sometimes atypical hyperplasia is discovered on a biopsy done for a different condition.

Related societies and associations:

Related pathology conferences:

Breast cancer and the Immune system

Immune response get trigger due to the every cancer, this is the first line of defence against the progression of any cancer. Relationship is present in between the immune system and tumour evolution in case of breast cancer as well. Variety of immune cells present in the environment of tumour which can help in arresting the progression of breast cancer. Therapies used for the treatment of breast cancer can modulate these immune cells in case of breast cancer. B lymphocytes secrete antigen-specific immunoglobulin which might be having anticancer properties. Patient who is suffering from breast cancer have increase population of B lymphocytes in the bone marrow as compare to normal person, this can be noticeable point for the treatment of breast cancer.

Related societies and associations:

Related pathology conferences:

Breast Implants

There are three general types of breast implant devices, defined by their filler material saline solution silicone, silicone gel and composite filler. The saline implant has an elastomer silicones shell filled with sterile saline solution during surgery the silicone implant has an elastomer silicone shell pre-filled with viscous silicone gel and the alternative composition implant featured miscellaneous fillers such as soy oil, polypropylene string etc. Saline implants, Silicone gel implants, Post-surgical recovery, Implant rupture. Breast implant emplacement is performed with five types of surgical incisions

Related societies and associations:

Related pathology conferences:

Surgery for Breast cancer

Most women with breast cancer have some type of surgery as part of their treatment. There are different types of breast surgery, and it may be done for different reasons, depending on the situation. surgery may be done to Remove as much of the cancer as possible, to Find out whether the cancer has spread to the lymph nodes under the arm, to Restore the breast’s shape after the cancer is removed, to Relieve symptoms of advanced cancer. There are two main types of surgery to remove breast cancer: Breast-conserving surgery and Mastectomy. Many women with early-stage cancers can choose between breast-conserving surgeries (BCS) and mastectomy. The main advantage of BCS is that a woman keeps most of her breast. But in most cases she will also need radiation. Women who have mastectomy for early stage cancers are less likely to need radiation. For some women, mastectomy may be a better option, because of the type of breast cancer, the large size of the tumour, previous treatment history, or certain other factors.

Related societies and associations:

Related pathology conferences:

Breast diseases

There are several categories of breast diseases which may cause infections, cysts and lumps with or without pain. Some of the breast diseases are benign (harmless) and some are malignant (which can spread). Most common breast diseases are mastitis (a bacterial infection), cysts, benign lumps and cancer. Women mostly are affected by the breast diseases where they are encouraged to start breast self-examination early in the life and to have regular mammography, if found suspicious they are generally offered with a combination of ultrasound and needle biopsy to work out the cause. Men are affected by breast diseases too, although not as often.

Related societies and associations:

Related pathology conferences:

Breast cancer Genes

It is estimated that one in eight women, or approximately 12%, will be diagnosed with breast cancer in her lifetime. However, women with certain genetic mutations have a higher lifetime risk of the disease. It’s estimated that 55 – 65% of women with the BRCA1 mutation will develop breast cancer before age 70. Approximately 45% of women with a BRCA2 mutation will develop breast cancer by age 70. Women with a BRCA1 or BRCA2 mutation who overcome their breast cancer with treatment appear to have a higher-than-average chance of developing a second cancer. This is called a recurrence. Cancers related to a BRCA1 mutation are also more likely to be triple negative breast cancer, which can be more aggressive and difficult to treat. You may find these statistics alarming. However, it’s important to note that less than 10% of women diagnosed with breast cancer have a BRCA mutation. Also, with early detection, the vast majority of breast cancer cases can be successfully treated—and that’s true even for people who have a BRCA1 or BRCA2 mutation.

Related societies and associations:

Related pathology conferences:

Breast cancer in Men

Breast cancer is often thought of as something that only affects women, but men can get it in rare cases. It develops in the small amount of breast tissue men have behind their nipples. It usually occurs in men over 60, but can very occasionally affect younger men. The outlook for breast cancer in men varies depending on how far it has spread by the time it's diagnosed. It may be possible to cure breast cancer it it's caught at an early stage. A cure is much less likely if the cancer isn't found until it has spread beyond the breast. In these cases, treatment can relieve your symptoms and help you live longer. The exact cause of breast cancer in men isn't known, but there are some things that increase your risk of getting it. These include: genes and family history – inheriting faulty versions of genes called BRCA1 or BRCA2 increases your risk of breast cancer, Conditions that can increase the level of oestrogen in the body – including obesity, Klinefelter syndrome and scarring of the liver, previous radiotherapy to the chest area. It's not certain if you can do anything to reduce your risk, but eating a balanced diet, losing weight if you're overweight and not drinking too much alcohol may help.

Related societies and associations:

Related pathology conferences:

Breast microcalcifications

Breast microcalcifications are small calcium deposits in the soft tissue of the breast. Indeed, breast microcalcifications are extremely common in women and are almost always a benign (non-cancerous) breast condition. So many different factors are taken into account when deciding if a potential lesion is malignant or not. Radiologists consider breast microcalcifications as a possible very early indicator for breast cancer. However, this may or may not be the case and only histological findings will confirm the suspicion. When evaluating microcalcifications, if there are combinations of findings that tend to lead to the same outcome (benign or malignant), it is generally true that those predictions carry even more weight. It can be said that as a general rule, when the microcalcifications are distributed in diffuse or bilateral arrangements, or with a round or punctuate shape, or scattered in dense breast tissue, the situation is usually benign.

Related societies and associations:

Related pathology conferences:

Breast cancer control and prevention

Raising general public awareness on the breast cancer problem and the mechanisms to control as well as advocating for appropriate policies and programmes are key strategies of population-based breast cancer control. Many low- and middle-income countries face now a double burden of breast and cervical cancer which represent top cancer killers in women over 30 years old. These countries need to implement combined strategies that address both public health problems in an effective and efficient way. Control of specific modifiable breast cancer risk factors as well as effective integrated prevention of non-communicable diseases which promotes healthy diet, physical activity and control of alcohol intake, overweight and obesity, could eventually have an impact in reducing the incidence of breast cancer in the long term. Treatment plan to achieve good outcome is affected by the biology of breast cancer. Breast Therapy includes Mastectomy, Breast-sparing surgery, and Radiation therapy, Chemotherapy, Stereotactic Radiosurgery, Hormone Therapy and Targeted Therapy.

Related societies and associations:

Related pathology conferences:

Survivorship of Breast cancer

If the breast cancer detection and treatment done at early stage it increase the survival rate. Life after breast cancer treatment gets changed like returning to some familiar things and new choices to make. After the last steps of treatment like radiation or diagnostic procedure is not the end of fighting against breast cancer. Instead person has to take care of lots of things like eating habits and exercise. Person has to eat which will help to prevent the recurrence of breast cancer. It also affects the sex life as well. Person will observe hair growth started again. Physical energy and functioning can also be getting affected after the breast cancer treatment. Level of oestrogen may also get lowered after the treatment which leads to the decrease in bone density. Bone density can be increased as well recurrence of breast cancer can be prevented with the help of exercise. Oncology rehabilitation helps to build strength as well as to overcome the physical defects. During oncology rehabilitation physical functioning as well as sense of well-being can be improved.

Related societies and associations:

Related pathology conferences:

The global breast cancer therapy market is expected to register a CAGR of 8.5% during the forecast period 2018-2023. The high incidence rate of breast cancer is now becoming a concern, and several pharmaceutical companies are increasingly investing in research on breast cancer. Thus, the market is expected to grow. Statistics say that around 50% of breast cancer cases and more than 58% of deaths occur in less developed countries. The National Cancer Institute has estimated that 246,660 cases of breast cancer were diagnosed in 2016. The high incidence and prevalence rate show that the breast cancer therapeutics market will boost over the forecast period. Today, increasing number of countries are adopting early cancer detection programs, around the world. If these initiatives continue, the demand for breast cancer therapeutics is bound to increase, with most of the cases being detected in the early stages. Along with the other factors, such as high investments on R&D, and the advancements in cancer biology and pharmacology promoting drug development, are driving the market. North America dominates the market for breast cancer therapy, due to the fact that the prevalence of breast cancer is on the rise in this region, along with an increase in R&D funding through public and private sectors. Asia-Pacific region is expected to grow at a significant pace, over the forecast period.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	June 28-29, 2019
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1
Poster Opportunity Closed	Click Here to View

International conference on Breast Pathology and Cancer June 28-29, 2019 Quality Airport Hotel Gardermoen, Oslo, Norway

Recommended Global Pathology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Renowned Speakers

Breast pathology and Cancer-2019

Why Oslo?

Breast Cancer

Breast Anatomy

Benign Breast conditions

Ductal carcinoma In Situ

Lobular carcinoma In Situ

Atypical hyperplasia

Breast cancer and the Immune system

Breast Implants

Surgery for Breast cancer

Breast diseases

Breast cancer Genes

Breast cancer in Men

Breast microcalcifications

Breast cancer control and prevention

Survivorship of Breast cancer

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues